Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3676756 | 0.83 | NR1H4 (0.33) | NR1H4 | |
| SCHEMBL3681023 | 0.82 | PTGS2 (0.36) | PTGS2CA2PTGS1ALDH1A1TSHR | |
| SCHEMBL3674810 | 0.81 | CA1 (0.40) | PTGS2CA2PTGS1ALDH1A1TSHR | |
| SCHEMBL5089962 | 0.80 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL3685258 | 0.80 | PTGS2 (0.35) | PTGS2PTGS1ALDH1A1TSHRTDP1 | |
| SCHEMBL3678838 | 0.79 | CA1 (0.36) | CA2PTGS1ALDH1A1TSHRTDP1 | |
| SCHEMBL3096012 | 0.75 | CA2 (0.50) | GABRA1GABRB2NR1H4PTGS2CA2 | |
| SCHEMBL30921753 | 0.73 | CA2 (0.48) | GABRA1GABRB2NR1H4PTGS2CA2 | |
| SCHEMBL5083703 | 0.70 | NR1H4 (0.31) | GABRA1GABRB2NR1H4 | |
| SCHEMBL3683214 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1785429-B1 | PROCESS FOR PRODUCING METALLOCENE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-10-03 | — | — | EP | disclosed |
| US-7652159-B2 | Process for producing metallocene compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20080319213-A1 | Process For Producing Metallocene Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-12-25 | — | — | US | disclosed |
| EP-1498178-B1 | Transition metal complex and process for producing the same | SUMITOMO CHEMICAL CO (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1785429-A1 | PROCESS FOR PRODUCING METALLOCENE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-05-16 | — | — | EP | disclosed |
| EP-1498178-A2 | Transition metal complex, process for producing the same, olefin polymerization catalyst containing the transition metal complex and process for producing olefin polymers | Sumitomo Chemical Company, Limited (JP) | 2005-01-19 | — | — | EP | disclosed |
| EP-0963990-B1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2004-10-06 | — | — | EP | disclosed |
| EP-0842939-B1 | OLEFIN POLYMERIZATION CATALYST CONTAINING A TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING OLEFIN POLYMERS | SUMITOMO CHEMICAL CO (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-6329478-B1 | SOLUBILITY IN SATURATED HYDROCARBON SOLVENTS | SUMITMO CHEMICAL COMPANY, LIMITED | 2001-12-11 | — | — | US | disclosed |
| US-6197990-B1 | REACTING CYCLOPENTADIENE AND METAL HYDRIDE IN PRESENCE OF AMINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-06 | — | — | US | disclosed |
| EP-0963990-A1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
| EP-0842939-A1 | TRANSITION METAL COMPLEX, PROCESS FOR THE PREPARATION THEREOF, POLYMERIZATION CATALYST FOR OLEFINS CONTAINING THE COMPLEX, AND PROCESS FOR PRODUCING OLEFIN POLYMERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319213-A1 | Process For Producing Metallocene Compound | H1-10, CNOT9, H1-4 | GABRA1 4857/4885GABRB2 4863/4885NR1H4 480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.